Autophagy in vitiligo: from melanocyte biology to the therapeutic evidence gap
Vitiligo is one of the most common and clinically challenging chronic depigmentary disorders. Current treatments, including corticosteroids, phototherapy, and JAK inhibitors, remain limited by incomplete or non-durable repigmentation, necessitating novel mechanism-based therapeutic strategies.